A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.

Ann Surg Oncol · 2021 · PMC7914039 · PMID 33641012

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

an encouraging trendp = 0.15not close (p > 0.1)

However, there was an encouraging trend in OS ( p = 0.15), which is particularly meaningful in the context of growing evidence that evaluation of OS may show the benefit of a cancer vaccine even if DFS does not.

also in 355 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.